<DOC>
	<DOCNO>NCT00135785</DOCNO>
	<brief_summary>Methamphetamine addictive stimulant drug strongly activate certain part brain . The purpose study determine effectiveness bupropion combination behavioral therapy treatment methamphetamine addiction .</brief_summary>
	<brief_title>Effectiveness Bupropion Combined With Behavioral Therapy Treating Methamphetamine Dependence - 2</brief_title>
	<detailed_description>Methamphetamine drug cause excess amount neurotransmitter dopamine norepinephrine release brain . This overload produce unusual alertness feeling elation . When body undergoes methamphetamine withdrawal , experience reduction dopamine norepinephrine . Bupropion antidepressant use treatment depression smoke cessation . Because function increase release dopamine norepinephrine brain , bupropion likely decrease negative effect methamphetamine withdrawal . The purpose study evaluate efficacy bupropion combine contingency management ( CM ) cognitive behavioral counseling ( CBT ) mean treat methamphetamine dependence . An initial 2-week screening process involve participant provide urine sample complete physical psychological assessment . If deem eligible remainder double-blind study , participant randomly assign receive either bupropion placebo course 12 week . Participants bupropion placebo group receive contingency management cognitive behavioral counseling . Participants report one two clinical research sit three time per week . At visit , participant examine study staff , provide urine sample , receive individual cognitive behavioral counseling session . At end 12 week , treatment stop . Participants return study site 30 day later evaluation assess possible lingering side effect .</detailed_description>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Meets DSMIV criterion methamphetamine dependence Females must use effective method contraception History current medical condition might interfere safe participation , active tuberculosis , unstable heart liver disease , unstable diabetes , symptomatic AIDS ( nonsymptomatic HIV infection exclusion ) , great 8 time upper limit normal liver screen function test ( SGOT SGPT ) Current neurological disorder ( e.g. , organic brain disease , dementia ) Major psychiatric disorder unrelated substance abuse , schizophrenia bipolar disorder ( assessed SCID medical history ) Suicide attempt within month prior enrollment and/or currently suicidal ( assessed SCID BDI II ) Currently prescription medication might interact study drug Currently dependent cocaine , opiates , alcohol , benzodiazepine , define DSMIVTR criterion History alcohol dependence within past three year History seizure disorder History anorexia bulimia Current hypertension uncontrolled medication History sensitivity bupropion Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>